Identification of serum biomarkers for aging and anabolic response

Immunity and Ageing

Volumn 8, Issue , 2011, Pages

  Banerjee, Camellia ^a   Ulloor, Jagadish ^a   Dillon, Edgar L ^b   Dahodwala, Qusai ^a   Franklin, Brittani ^a   Storer, Thomas ^a   Sebastiani, Paola ^b   Sheffield Moore, Melinda ^c   Urban, Randall J ^c   Bhasin, Shalender ^a   Montano, Monty ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Age; Biomarker; Testosterone

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 3; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12P40; INTERLEUKIN 7; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; IMMUNE RESPONSE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM;

EID: 79959214454     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-8-5     Document Type: Article

References (43)

1. Yarasheski KE. Exercise, aging, and muscle protein metabolism. J Gerontol A Biol Sci Med Sci 2003, 58(10):M918-22. 10.1093/gerona/58.10.M918, 14570859.
2. Peake JM, Della Gatta P, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 2010, 298(6):R1485-95. 10.1152/ajpregu.00467.2009, 20393160.
3. Rantanen T, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000, 55(3):M168-73. 10.1093/gerona/55.3.M168, 10795731.
4. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 2006, 54(1):56-62. 10.1111/j.1532-5415.2005.00540.x, 16420198.
5. Dudgeon WD, et al. Counteracting muscle wasting in HIV-infected individuals. HIV Med 2006, 7(5):299-310. 10.1111/j.1468-1293.2006.00380.x, 16945075.
6. Lynch GS, Schertzer JD, Ryall JG. Therapeutic approaches for muscle wasting disorders. Pharmacol Ther 2007, 113(3):461-87. 10.1016/j.pharmthera.2006.11.004, 17258813.
7. Filippatos GS, Anker SD, Kremastinos DT. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 2005, 8(3):249-54. 10.1097/01.mco.0000165002.08955.5b, 15809526.
8. Strassburg S, Springer J, Anker SD. Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 2005, 37(10):1938-47. 10.1016/j.biocel.2005.03.013, 15927519.
9. Bhasin S, et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2000, 283(6):763-70. 10.1001/jama.283.6.763, 10683055.
10. Jenkins MW, et al. Phenotyping transgenic embryonic murine hearts using optical coherence tomography. Appl Opt 2007, 46(10):1776-81. 10.1364/AO.46.001776, 17356621.
11. Bhasin S, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001, 281(6):E1172-81.
12. Sinha-Hikim I, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002, 283(1):E154-64.
13. Bhasin S, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005, 90(2):678-88.
14. Singh AB, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 2002, 87(1):136-43. 10.1210/jc.87.1.136, 11788637.
15. Bhasin S, et al. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone. J Clin Endocrinol Metab 2009, 94(11):4224-33. 10.1210/jc.2009-1434, 2775648, 19837911.
16. Bhasin S, et al. Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2006, 2(3):146-59. 10.1038/ncpendmet0120, 2072878, 16932274.
17. Gooren LJ. Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl 12(2):136-51.
18. Basaria S, et al. Adverse events associated with testosterone administration. N Engl J Med 363(2):109-22.
19. Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001, 3(11):1009-13. 10.1038/ncb1101-1009, 11715022.
20. Stitt TN, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004, 14(3):395-403. 10.1016/S1097-2765(04)00211-4, 15125842.
21. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002, 60(10 Pt 2):S1-14. discussion S68-84, 85-7.
22. Hislop MS, et al. Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. Eur J Endocrinol 1999, 141(1):40-6. 10.1530/eje.0.1410040, 10407221.
23. Sih R, et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997, 82(6):1661-7. 10.1210/jc.82.6.1661, 9177359.
24. Schaap LA, et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006, 119(6):526 e9-17.
25. Montano M, et al. Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab 2007, 92(7):2793-802. 10.1210/jc.2006-2722, 17440010.
26. Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Executive Summary. Testosterone and aging: clinical research directions 2004, 1-10. Washington, DC, Liverman C, Blazer D.
27. Ferrando AA, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002, 282(3):E601-7.
28. Urban RJ, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995, 269(5 Pt 1):E820-6.
29. Risteli J, et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988, 34(4):715-8.
30. Shurin GV, et al. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007, 39(2):123-9. 10.1016/j.cyto.2007.06.006, 17689975.
31. Perrini S, et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205(3):201-10.
32. Kim HR, et al. Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 2006, 107(7):2855-62. 10.1182/blood-2005-09-3560, 1440715, 16357322.
33. Phillips JA, et al. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J Immunol 2004, 173(8):4867-74.
34. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002, 37(2-3):455-63. 10.1016/S0531-5565(01)00213-3, 11772533.
35. Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol 2007, 28(1):33-8. 10.1016/j.it.2006.11.002, 17126601.
36. Yoshikawa H, et al. Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma. J Neuroimmunol 2006, 175(1-2):169-75. 10.1016/j.jneuroim.2006.02.012, 16574246.
37. Tanaka Y, et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993, 361(6407):79-82. 10.1038/361079a0, 7678446.
38. Swift ME, et al. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001, 117(5):1027-35. 10.1046/j.0022-202x.2001.01539.x, 11710909.
39. Adler AS, et al. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 2007, 21(24):3244-57. 10.1101/gad.1588507, 2113026, 18055696.
40. Carlson ME, et al. Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 2009, 8(6):676-89. 10.1111/j.1474-9726.2009.00517.x, 2783265,2783265, 19732043.
41. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008, 454(7203):528-32. 10.1038/nature07034, 18552838.
42. Chien KR, Karsenty G. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 2005, 120(4):533-44. 10.1016/j.cell.2005.02.006, 15734685.
43. Tenover JL. Testosterone replacement therapy in older adult men. Int J Androl 1999, 22(5):300-6. 10.1046/j.1365-2605.1999.00184.x, 10509230.